Our findings revealed that the potent HDAC inhibitor MPT0E028 significantly increased the BW, reduced the emphysema severity, increased pulmonary function, and mitigated pulmonary inflammation in emphysematous mice. The gene discussed is HDAC9; the disease is pulmonary emphysema.